Skip to main content
. 2022 Sep 8;3(10):1780–1784. doi: 10.34067/KID.0001012022

Figure 1.

Figure 1.

Biomarker competition in AKI. There may be successful biomarkers among the current candidates for becoming an ideal biomarker and help improve early detection, management and outcomes of AKI. However, there are many barriers for their implementation like: availability, costs, unique set of AKI case-mix presentation and pathophysiology, the need of individualized panel of biomarkers for each setting, etc. Further research is needed to advance biomarkers to bedside.